Newborns in Level III Services in Alsace From Mothers With COVID-19
COVID-Néo
Retrospective Clinical Study of the Care and Follow-up in the First Month of Life of Newborns in Level III Services in Alsace From Mothers With COVID-19
1 other identifier
observational
50
1 country
1
Brief Summary
Very little is known about the impact on the newborn of late pre-partum maternal SARS-CoV-2 infection. Care without separation of the mother and her newborn with continued breastfeeding has been advocated in France and by the WHO but is being debated in some countries. Assessment of the development of newborns in their first month of life with this strategy associated with close and secure follow-up. Importance of reporting the potential benefits / risks of this treatment to guide the care of newborns in a persistent epidemic context in a particularly affected region.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2020
CompletedFirst Submitted
Initial submission to the registry
October 14, 2021
CompletedFirst Posted
Study publicly available on registry
October 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2021
CompletedNovember 18, 2021
October 1, 2021
1.4 years
October 14, 2021
November 17, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Retrospective description of the care and follow-up in the first month of life of newborns in level III services in Alsace from mothers with COVID-19
Files analysed retrospectively from March 01, 2020 to Jun 30, 2020 will be examined]
Eligibility Criteria
Newborns born between March 1 and June 30, 2020 to COVID 19 from positive mothers in Strasbourg University Hospital or Mulhouse Hospital.
You may qualify if:
- Newborns born between March 1 and June 30, 2020 to COVID 19
- From positive mothers in Strasbourg University Hospital or Mulhouse Hospital.
- Parents' non-opposition to the analysis of hospitalization data for children contained in the medical file
You may not qualify if:
- \- Parents' opposition to the analysis of hospitalization data for children contained in the medical file
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de Médecine et Réanimation du Nouveau-né - Hôpitaux Universitaires de Strasbourg
Strasbourg, 67091, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 14, 2021
First Posted
October 15, 2021
Study Start
June 1, 2020
Primary Completion
October 31, 2021
Study Completion
October 31, 2021
Last Updated
November 18, 2021
Record last verified: 2021-10